Serum ferritin elevation and acute lung injury in rats subjected to hemorrhage: Reduction by mepacrine treatment

Experimental Lung Research

Volumn 30, Issue 7, 2004, Pages 571-584

  Park, Yoon Yub ^a   Hybertson, Brooks M ^a   Wright, Richard M ^a   Fini, Mehdi A ^a   Elkins, Nancy D ^a   Repine, John E ^a  

^a Box C322 ^*

Author keywords

Inflammation; Iron; Neutrophils; Oxidants; Shock

Indexed keywords

FERRITIN; MEPACRINE; MYELOPEROXIDASE; PROTEIN;

ANIMAL MODEL; ARTICLE; BLEEDING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; IRON BLOOD LEVEL; LEUKOCYTE COUNT; LUNG INJURY; LUNG LAVAGE; MALE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; RAT;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; ENZYME INHIBITORS; FERRITINS; HEMORRHAGE; LEUKOCYTES; MALE; OXIDANTS; PNEUMONIA; QUINACRINE; RATS; RATS, SPRAGUE-DAWLEY; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 4444352807     PISSN: 01902148     EISSN: None     Source Type: Journal    
DOI: 10.1080/01902140490489207     Document Type: Article

References (54)

1. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al: The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149:818-824.
2. Hudson LD, Milberg JA, Anardi D, Maunder RJ: Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med. 1995;151:293-301.
3. Repine JE: Scientific perspectives on adult respiratory distress syndrome. Lancet. 1992;339:466-469.
4. Ware LB, Matthay MA: The acute respiratory distress syndrome. N Engl J Med. 2000;342:1334-349.
5. Shimabukuro DW, Sawa T, Cropper MA: Injury and repair in lung and airways. Crit Care Med. 2003;31:S524-S531.
6. Abraham E: Neutrophils and acute lung injury. Crit Care Med. 2003;31:S195-S199.
7. Chow CW, Herrera Abreu MT, Suzuki T, Downey GP: Oxidative stress and acute lung injury. Am J Respir Cell Mol Biol. 2003;29:427-431.
8. Quinlan GJ, Evans TW, Gutteridge JM: Iron and the redox status of the lungs. Free Radic Biol Med. 2002;33:1306-1313.
9. Upton RL, Chen Y, Mumby S, Gutteridge JM, Anning PB, Nicholson AG, et al: Variable tissue expression of transferrin receptors: relevance to acute respiratory distress syndrome. Eur Respir J. 2003;22:335-341.
10. Ghio AJ, Carter JD, Richards JH, Richer LD, Grissom CK, Elstad MR: Iron and iron-related proteins in the lower respiratory tract of patients with acute respiratory distress syndrome. Crit Care Med. 2003;31:395-400.
11. Balla G, Jacob HS, Balla J, Rosenberg M, Nath K, Apple F, et al: Ferritin: a cytoprotective antioxidant strategem of endothelium. J Biol Chem. 1992;267:18148-18153.
12. Hybertson BM, Connelly KG, Buser RT, Repine JE: Ferritin and desferrioxamine attenuate xanthine oxidase-dependent leak in isolated perfused rat lungs. Inflammation. 2002:26:153-159.
13. Park YY, Hybertson BM, Wright RM, Repine JE: Serum ferritin increases in hemorrhaged rats that develop acute lung injury: effect of an iron-deficient diet. Inflammation. 2003;27:257-263.
14. Connelly KG, Moss M, Parsons PE, Moore EE, Moore FA, Giclas PC, et al: Serum ferritin as a predictor of the acute respiratory distress syndrome. Am J Respir Crit Care Med. 1997;155:21-25.
15. Sharkey RA, Donnelly SC, Connelly KG, Robertson CE, Haslett C, Repine JE: Initial serum ferritin levels in patients with multiple trauma and the subsequent development of acute respiratory distress syndrome. Am J Respir Crit Care Med. 1999;159:1506-1509.
16. Connelly KG, Repine JE: Markers for predicting the development of acute respiratory distress syndrome. Annu Rev Med. 1997;48:429-445.
17. Abraham E, Carmody A, Shenkar R, Arcaroli J: Neutrophils as early immunologic effectors in hemorrhage- or endotoxemia-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2000;279:L1137-L1145.
18. Torti FM, Torti SV: Regulation of ferritin genes and protein. Blood. 2002;99:3505-3516.
19. Miller LL, Miller SC, Torti SV, Tsuji Y, Torti FM: Iron-independent induction of ferritin H chain by tumor necrosis factor. Proc Natl Acad Sci U S A. 1991;88:4946-4950.
20. Shenkar R, Abraham E: Mechanisms of lung neutrophil activation after hemorrhage or endotoxemia: roles of reactive oxygen intermediates, NF-kappa B, and cyclic AMP response element binding protein. J Immunol. 1999;163:954-962.
21. Anderson BO, Moore EE, Moore FA, Leff JA, Terada LS, Harken AH, et al: Hypovolemic shock promotes neutrophil sequestration in lungs by a xanthine oxidase-related mechanism. J Appl Physiol. 1991;71:1862-1865.
22. McCord JM: Oxygen-derived free radicals in post-ischemic tissue injury. N Engl J Med. 1985;312:159-163.
23. Schwartz MD, Repine JE, Abraham E: Xanthine oxidase-derived oxygen radicals increase lung cytokine expression in mice subjected to hemorrhagic shock. Am J Respir Cell Mol Biol. 1995;12:434-440.
24. Tan S, Yokoyama Y, Dickens E, Cash TG, Freeman BA, Parks DA: Xanthine oxidase activity in the circulation of rats following hemorrhagic shock. Free Radic Biol Med. 1993;15:407-414.
25. Balla J, Nath KA, Balla G, Juckett MB, Jacob HS, Vercellotti GM: Endothelial cell heme oxygenase and ferritin induction in rat lung by hemoglobin in vivo. Am J Physiol. 1995;268:L321-L327.
26. Reif DW: Ferritin as a source of iron for oxidative damage [see comments]. Free Radic Biol Med. 1992;12:417-427.
27. Foldes-Filep E, Filep JG: Mepacrine inhibits fMLP-induced activation of human neutrophil granulocytes, leukotriene B4 formation, and fMLP binding. J Leukoc Biol. 1992;52:545-550.
28. Stuhlmeier KM: Effects of quinacrine on endothelial cell morphology and transcription factor-DNA interactions. Biochim Biophys Acta. 2000;1524:57-65.
29. Stuhlmeier KM: Mepacrine inhibits matrix metalloproteinases-1 (MMP-1) and MMP-9 activation in human fibroblast-like synoviocytes. J Rheumatol. 2003;30:2330-2337.
30. Caro AA, Cederbaum AI: Role of phospholipase A2 activation and calcium in CYP2E1-dependent toxicity in HepG2 cells. J Biol Chem. 2003;278:33866-33877.
31. Arndt H, Russell JB, Kurose I, Kubes P, Granger DN: Mediators of leukocyte adhesion in rat mesenteric venules elicited by inhibition of nitric oxide synthesis. Gastroenterology. 1993;105:675-680.
32. Crooks SW, Stockley RA: Leukotriene B4. Int J Biochem Cell Biol. 1998;30:173-178.
33. Busse WW: Leukotrienes and inflammation. Am J Respir Crit Care Med. 1998;157:S210-S213; discussion S247-S248.
34. Stephenson AH, Lonigro AJ, Hyers TM, Webster RO, Fowler AA: Increased concentrations of leukotrienes in bronchoalveolar lavage fluid of patients with ARDS or at risk for ARDS. Am Rev Respir Dis. 1988;138:714-719.
35. Tsukahara Y, Morisaki T, Horita Y, Torisu M, Tanaka M: Phospholipase A2 mediates nitric oxide production by alveolar macrophages and acute lung injury in pancreatitis. Ann Surg. 1999;229:385-392.
36. Espinoza E, Perez-Arellano JL, Vicente B, Muro A: Cytoplasmic signalling pathways in alveolar macrophages involved in the production of nitric oxide after stimulation with excretory/secretory antigens of Toxocara canis. Parasite Immunol. 2002;24:535-544.
37. Krawisz JE, Sharon P, Stenson WF: Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Gastroenterology. 1984;87:1344-1350.
38. Mullane KM, Kraemer R, Smith B: Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods. 1985;14:157-167.
39. Kim DK, Fukuda T, Thompson BT, Cockrill B, Hales C, Bonventre JV: Bronchoalveolar lavage fluid phospholipase A2 activities are increased in human adult respiratory distress syndrome. Am J Physiol. 1995;269:L109-L118.
40. Tsuji Y, Torti SV, Torti FM: Activation of the ferritin H enhancer, FER-1, by the cooperative action of members of the AP1 and Sp1 transcription factor families. J Biol Chem. 1998;273:2984-2992.
41. Gabrijelcic J, Acuna A, Profita M, Paterno A, Chung KF, Vignola AM, et al: Neutrophil airway influx by platelet-activating factor in asthma: role of adhesion molecules and LTB4 expression. Eur Respir J. 2003;22:290-297.
42. Shames RS, Goetzl EJ: Activation of human neutrophil LFA-1 (CD11a) by leukotriene B4. Inflammation. 1993;17:371-382.
43. Seo SM, McIntire LV, Smith CW: Effects of IL-8, Gro-alpha, and LTB(4) on the adhesive kinetics of LFA-1 and Mac-1 on human neutrophils. Am J Physiol Cell Physiol. 2001;281:C1568-C1578.
44. Alten R, Gromnica-Ihle E, Pohl C, Emmerich J, Steffgen J, Roscher R, et al: Inhibition of leukotriene B4-induced CD11B/CD18 (Mac-1) expression by BIIL 284, a new long acting LTB4 receptor antagonist, in patients with rheumatoid arthritis. Ann Rheum Dis. 2004;63:170-176.
45. Friedrich EB, Tager AM, Liu E, Pettersson A, Owman C, Munn L, et al: Mechanisms of leukotriene B4-triggered monocyte adhesion. Arterioscler Thromb Vasc Biol. 2003;23:1761-1767.
46. Aiello RJ, Bourassa PA, Lindsey S, Weng W, Freeman A, Showell HJ: Leukotriene B4 receptor antagonism reduces monocytic foam cells in mice. Arterioscler Thromb Vasc Biol. 2002;22:443-449.
47. Birke FW, Meade CJ, Anderskewitz R, Speck GA, Jennewein HM: In vitro and in vivo pharmacological characterization of BIIL 284, a novel and potent leukotriene B(4) receptor antagonist. J Pharmacol Exp Ther. 2001;297:458-466.
48. Canham EM, Shoemaker SA, Tate RM, Harada RN, McMurtry IF, Repine JE: Mepacrine but not methylprednisolone decreases acute edematous lung injury after injection of phorbol myristate acetate in rabbits. Am Rev Respir Dis. 1983;127:594-598.
49. Lee YM, Hybertson BM, Terada LS, Repine AJ, Cho HG, Repine JE: Mepacrine decreases lung leak in rats given interleukin-1 intratracheally. Am J Repir Crit Care Med. 1997;155:1624-1628.
50. Hybertson BM, Lee YM, Cho HG, Cho OJ, Repine JE: Alveolar type II cell abnormalities and peroxide formation in lungs of rats given IL-1 intratracheally. Inflammation. 2000;24:289-303.
51. Jacobs A, Worwood M: Ferritin in serum. Clinical and biochemical implications. N Engl J Med. 1975;292:951-956.
52. Gabay JE: Antimicrobial proteins with homology to serine proteases. Ciba Found Symp. 1994;186:237-247; discussion 247-249.
53. Rogers JT, Bridges KR, Durmowicz GP, Glass J, Auron PE, Munro HN: Translational control during the acute phase response. Ferritin synthesis in response to interleukin-1. J Biol Chem. 1990;265:14572-14578.
54. Smith JJ, O'Brien-Ladner AR, Kaiser CR, Wesselius LJ: Effects of hypoxia and nitric oxide on ferritin content of alveolar cells. J Lab Clin Med 2003;141:309-317.